Home › Calculator › HLBBF Dividend Calculator 2026
HLBBF DRIP Calculator & Dividend Yield 2026
2.50% YieldHealthcareH. Lundbeck A/S · OTC
Price: $7.10 · Annual div: $0.1777/share · Frequency: annual · Payout ratio: 6% · Ex-div: 2026-03-20
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
HLBBF Dividend Yield
HLBBF (H. Lundbeck A/S) has a dividend yield of 2.50%, based on an annual dividend of $0.1777 per share and a price of $7.10. Over the last 12 months it paid $0.1777 per share — a trailing yield of 2.50%. Dividends are paid annual.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When HLBBF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
HLBBF Dividend History — Last 10 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-03-20Latest | 2026-03-23 | $0.1777 | 5.07% | $6.21 |
| 2025-03-28 | 2025-03-31 | $0.1373 | 2.45% | $5.60 |
| 2024-03-21 | 2024-03-25 | $0.1030 | 2.17% | $4.75 |
| 2023-03-22 | 2023-03-24 | $0.0840 | 3.72% | $4.24 |
| 2022-03-24 | 2022-03-28 | $0.0739 | — | — |
| 2021-03-24 | 2021-03-26 | $0.0994 | — | — |
| 2020-03-25 | 2020-03-27 | $0.1487 | — | — |
| 2019-03-27 | 2019-03-29 | $0.4521 | — | — |
| 2018-03-21 | 2018-03-23 | $0.3294 | — | — |
| 2017-03-31 | 2017-04-04 | $0.0881 | — | — |
About H. Lundbeck A/S (HLBBF) — Dividend Analysis 2026
H. Lundbeck A/S operates as an international biopharmaceutical entity, focusing its efforts on the entire lifecycle of pharmaceutical products—from initial research and development to manufacturing and global sales. The firm primarily specializes in therapeutic solutions for psychiatric and neurological disorders across Europe, North America, and other worldwide regions. Among its prominent offerings are Abilify Maintena and Rexulti/Rxulti, prescribed for schizophrenia; Brintellix/Trintellix and Rexulti/Rxulti for the management of depression; Vyepti for the prevention of migraine attacks; and Northera, used to treat symptomatic neurogenic orthostatic hypotension. Lundbeck's diverse product lineup further includes Azilect for Parkinson's disease, Cipralex/Lexapro for depression, Ebixa for Alzheimer's disease, Onfi for Lennox-Gastaut syndrome, Sabril for epilepsy, and Xenazine for chorea associated with Huntington's disease, among others. The company's pharmaceuticals are primarily distributed to pharmaceutical wholesalers, retail pharmacies, and healthcare facilities like hospitals. Demonstrating a commitment to innovation and evidence-based medicine, Lundbeck has forged strategic alliances, including an agreement with Verantos to gather real-world evidence supporting migraine therapies, and a partnership with Rgenta Therapeutics, Inc. Founded in 1915, H. Lundbeck A/S maintains its corporate headquarters in Valby, Denmark.
Similar dividend stocks to HLBBF
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full HLBBF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open HLBBF position with:
🌍 HLBBF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold HLBBF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.50% | -0.30% | $250 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.13% | -0.67% | $213 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.00% | -0.80% | $200 / yr |
| 🇬🇧 UK ISA | 0% | 2.50% | -0.30% | $250 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.28% | -0.52% | $228 / yr |
| 🇨🇦 TFSA | 0% | 2.50% | -0.30% | $250 / yr |
| 🇨🇦 CA Taxable | 25% | 1.88% | -0.92% | $188 / yr |
| 🇦🇺 Super (pension) | 15% | 2.13% | -0.67% | $213 / yr |
| 🇦🇺 AU Taxable | 30% | 1.75% | -1.05% | $175 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.84% | -0.96% | $184 / yr |
| 🇫🇷 FR Taxable | 30% | 1.75% | -1.05% | $175 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 HLBBF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.18/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 HLBBF Dividend Payment Schedule
HLBBF pays annually — 1 payment per year.
📊 HLBBF vs Healthcare Benchmarks
How HLBBF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HLBBF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ HLBBF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HLBBF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
H. Lundbeck A/S (HLBBF) is currently trading at $7.10, trading near its 52-week high. The current dividend yield is 2.50% based on an annual payout of $0.1777 per share.
HLBBF (H. Lundbeck A/S) — 2.50% Dividend Yield Analysis
H. Lundbeck A/S (HLBBF) is a healthcare stock currently trading at $7.10 with a dividend yield of 2.50%. It pays an annual dividend of $0.1777 per share. The payout ratio of 6% suggests the dividend is well-covered by earnings. Over the past 5 years, HLBBF's dividend has declined at an average rate of 25.4% a year.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest HLBBF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the HLBBF dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.